Silver Book Fact

The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with age-related macular degeneration (AMD) is $575 million.

Rein D, Zhang P, Wirth K, Lee P, et al. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein D, Zhang P, Wirth K, Lee P, et al
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Nearly all patients with type 1 diabetes, and greater than 60% of patients with type 2, develop retinopathy within the first two decades of the disease.  
  • Increase in trouble seeing with age, 2010
    10.3% of the non-institutionalized adults 65 years and older have some trouble seeing, even with glasses or contacts.  That number increases to 16.5% in adults 75 years and older.  
  • Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in people over the age of 65.  
  • Global DR Prevalence
    The overall prevalence of global DR is 34.6%—6.96% for PDR, 6.81% for DME, and 10.2% for vision-threatening DR.  
  • Americans 65+ that have severe visual impairment
    6.5 million Americans over the age of 65 have severe visual impairment that threatens to limit their mobility, independence, and quality of life.